Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

856 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Letrozole sensitizes breast cancer cells to ionizing radiation.
Azria D, Larbouret C, Cunat S, Ozsahin M, Gourgou S, Martineau P, Evans DB, Romieu G, Pujol P, Pèlegrin A. Azria D, et al. Among authors: evans db. Breast Cancer Res. 2005;7(1):R156-63. doi: 10.1186/bcr969. Epub 2004 Dec 7. Breast Cancer Res. 2005. PMID: 15642164 Free PMC article.
Synergistic activity of letrozole and sorafenib on breast cancer cells.
Bonelli MA, Fumarola C, Alfieri RR, La Monica S, Cavazzoni A, Galetti M, Gatti R, Belletti S, Harris AL, Fox SB, Evans DB, Dowsett M, Martin LA, Bottini A, Generali D, Petronini PG. Bonelli MA, et al. Among authors: evans db. Breast Cancer Res Treat. 2010 Nov;124(1):79-88. doi: 10.1007/s10549-009-0714-5. Epub 2010 Jan 7. Breast Cancer Res Treat. 2010. PMID: 20054642
Molecular response to aromatase inhibitor treatment in primary breast cancer.
Mackay A, Urruticoechea A, Dixon JM, Dexter T, Fenwick K, Ashworth A, Drury S, Larionov A, Young O, White S, Miller WR, Evans DB, Dowsett M. Mackay A, et al. Among authors: evans db. Breast Cancer Res. 2007;9(3):R37. doi: 10.1186/bcr1732. Breast Cancer Res. 2007. PMID: 17555561 Free PMC article. Clinical Trial.
Increase in response rate by prolonged treatment with neoadjuvant letrozole.
Dixon JM, Renshaw L, Macaskill EJ, Young O, Murray J, Cameron D, Kerr GR, Evans DB, Miller WR. Dixon JM, et al. Among authors: evans db. Breast Cancer Res Treat. 2009 Jan;113(1):145-51. doi: 10.1007/s10549-008-9915-6. Epub 2008 Feb 9. Breast Cancer Res Treat. 2009. PMID: 18264759 Clinical Trial.
Effectiveness and molecular interactions of the clinically active mTORC1 inhibitor everolimus in combination with tamoxifen or letrozole in vitro and in vivo.
Martin LA, Pancholi S, Farmer I, Guest S, Ribas R, Weigel MT, Thornhill AM, Ghazoui Z, A'Hern R, Evans DB, Lane HA, Johnston SR, Dowsett M. Martin LA, et al. Among authors: evans db. Breast Cancer Res. 2012 Oct 17;14(5):R132. doi: 10.1186/bcr3330. Breast Cancer Res. 2012. PMID: 23075476 Free PMC article.
856 results